Mycoplasma Infection (1)
-
Upload
irina-tarane -
Category
Documents
-
view
229 -
download
0
Transcript of Mycoplasma Infection (1)
-
8/13/2019 Mycoplasma Infection (1)
1/35
By Dr.Sujith S
-
8/13/2019 Mycoplasma Infection (1)
2/35
Species Mycoplasma pneumoniae
Mycoplasma hominis
Mycoplasma genitalium Ureaplasma urealyticum
-
8/13/2019 Mycoplasma Infection (1)
3/35
Pathogenesis Pathogenic organisms for humans and animals possess
specialized tip organelles that mediate theirinteractions with host cells.
This host-adapted survival is achieved by i)surfaceparasitism of target cells
ii) the acquisition of essential biosynthetic precursors
iii) cell entry and intracellular survival.
-
8/13/2019 Mycoplasma Infection (1)
4/35
Toll-like receptor 2for binding of Mycoplasma andactivation of inf lammatory mediators, includingcytokines.
M. pneumoniae grows under both aerobic andanaerobic conditions ,isolated on media supplementedwith serum.
The organism most commonly exists in a filamentousform and has adherence proteins that attach toepithelial membranes with particular affinity forrespiratory tract epithelium
-
8/13/2019 Mycoplasma Infection (1)
5/35
An immune-mediated mechanism in infants andyoung children developing pneumonia.
In addition, the antibodies produced against theglycolipid antigens of M. pneumoniae may act asautoantibodies, since they crossreact with human redcells and brain cells.
-
8/13/2019 Mycoplasma Infection (1)
6/35
Epidemiology M. pneumoniae is transmitted from person-to-person
by infected respiratory droplets during close contact.
The incubation period after exposure averages threeweeks .
Infection occurs most frequently during the fall andwinter but may develop year-round
-
8/13/2019 Mycoplasma Infection (1)
7/35
Mycoplasma pneumoniaeone of the most commoncauses of atypical pneumonia
Atypical pneumonia
account for 7 to 20% ofcommunity-acquired pneumonia
The incidence may be higher in patients with milderdisease that can be managed without hospitalization
-
8/13/2019 Mycoplasma Infection (1)
8/35
Many infections due to M. pneumoniae areasymptomatic.
The signs and symptoms vary according to the stage ofillness
Headache, malaise, and low grade fever.
Chills are frequent.
-
8/13/2019 Mycoplasma Infection (1)
9/35
Cough due to M. pneumoniae infection ranges fromnonproductive to mildly productive, with sputumdiscoloration occurring late in the disease.
Wheezing may occur
Pharyngitis
Rhinorrhea and
Ear pain
-
8/13/2019 Mycoplasma Infection (1)
10/35
Extrapulmonary manifestations These manifestations include
Hemolysis
Skin rashJoint involvement
Symptoms and signs indicative of gastrointestinal tract,central nervous system, and heart disease..
-
8/13/2019 Mycoplasma Infection (1)
11/35
HaemolysisAntibodies (IgM)I antigen on erythrocyte
membranes appear during the course ; produce a coldagglutinin response in about 60 % of patients .
-
8/13/2019 Mycoplasma Infection (1)
12/35
Skin Disease Dermatologic manifestationsa mild erythematous
maculopapular / vesicular rash to the Stevens-Johnsonsyndrome.
16 % patients with Stevens-Johnson syndrome hadevidence of mycoplasma infection.
-
8/13/2019 Mycoplasma Infection (1)
13/35
Central Nervous
SystemCNS involvement occurs most frequently in children,
with encephalitisas the most frequent manifestation.
Other manifestations include aseptic meningitis,peripheral neuropathy, transverse myelitis, cranialnerve palsies andcerebellar ataxia .
Acute transverse myelitis (ATM) and acute disseminated
encephalomyelitis (ADEM)
most severecomplications .
59 percent of patients presenting with spinal cordinvolvement suffered permanent neurologic sequelae .
-
8/13/2019 Mycoplasma Infection (1)
14/35
Other Systems Rheumatologic symptomsincluding tender joints
and muscles and polyarthritis.
Arthritis is believed to result from immune-mediatedmechanisms
M. pneumoniae has been isolated from synovial fluidin some patients with polyarthritis.
-
8/13/2019 Mycoplasma Infection (1)
15/35
Cardiac or renal involvement -unusual .
Rhythm disturbances, congestive heart failure, chest
pain, and conduction abnormalities on theelectrocardiogram.
Clinically significant glomerulonephritis is a rarecomplication that is presumed to be secondary to
immune complex deposition
-
8/13/2019 Mycoplasma Infection (1)
16/35
Chest X-Ray Bronchopneumonia Plate-like atelectasis Nodular infiltration
Hilar adenopathy The most common radiographic finding is the
peribronchial pneumonia pattern, which consists of athickened bronchial shadow, streaks of interstitialinfiltration, and areas of atelectasis; these changes have a
predilection for the lower lobes. Nodular infiltrates and hilar adenopathyless common,
and result in a broader differential diagnosis, includingtuberculosis, mycotic infections, and sarcoidosis
-
8/13/2019 Mycoplasma Infection (1)
17/35
Lab Diagnosis Subclinical evidence of hemolytic anemia is present in
the majority of patients with pneumoniapositiveCoombs' test and elevated reticulocyte count.
Cold agglutinin titers are elevated in 50 percent ofpatients with mycoplasma disease, and the titer
usually exceeds 1:128 in patients with pneumonia
With overt hemolysis, titers may be as high as 1:50,000.
-
8/13/2019 Mycoplasma Infection (1)
18/35
Elevated Cold Agglutinin Titres Infectious Mononucleosis secondary to Epstein Barr
virus
CytomegalovirusAdenovirus pneumonia
Viral illness
Lymphoma and Collagen vascular disorders
-
8/13/2019 Mycoplasma Infection (1)
19/35
The white blood cell count (WBC) normal75 to 90percent of cases.
Thrombocytosis can occur
acute phase response.
-
8/13/2019 Mycoplasma Infection (1)
20/35
CSF-Lymphocytic pleocytosis, elevated protein, andnormal glucose.
Isolation of M. pneumoniae in CSF - possible.
A culture is more likely to be positive in encephalitisrather than myelitis.
PCR testing for Mycoplasma in the CSF can also be
performed.
-
8/13/2019 Mycoplasma Infection (1)
21/35
Treatment Treatment options for outpatient community-acquired
pneumonia are presented in the 2007 consensusIDSA/ATS guideline:
Macrolide antibiotics (azithromycin, clarithromycinorerythromycin)first line treatment .
Azithromycin (500 mg orally once daily, initially
followed by 250 mg orally for 4 days) has become themost commonly used drug regimen.
-
8/13/2019 Mycoplasma Infection (1)
22/35
Adjunctive Therapy For hemolytic anemia, case reports indicate some
patients respond to warming, steroid therapy, possiblyplasmapheresis.
For CNS disease, therapy with steroids,
antiinflammatory drugs, diuretics, and plasmaexchange ,used in addition to antibiotics.
-
8/13/2019 Mycoplasma Infection (1)
23/35
M.Hominis Epidemiology:M. hominis is part of the normal genital
flora of many sexually experienced men and women
Infants & childrren:Newborns are likely to becomecolonized during passage through the birth canal..
-
8/13/2019 Mycoplasma Infection (1)
24/35
The organism Mycoplasma are the smallest free-living bacteria. M.
hominis cannot be visualized by Gram stain.
M. Hominisproduces nonhemolytic colonies onsheep blood agar after three to five days of incubation.
M. hominis does not alter the appearance of bloodculture media; therefore,routine blind subculturingonto blood is required for detection.
-
8/13/2019 Mycoplasma Infection (1)
25/35
For optimizing the recovery of M. hominis, clinicalspecimens should be immediately inoculated ontoculture media and not allowed to dry.
After plating, cultures should be promptly incubatedor kept at 4C.
The best laboratory culture media is beef heart
infusion broth (also known as pleuropneumonia-likeorganism) (PPLO) broth with fresh yeast extract andhorse serum.
-
8/13/2019 Mycoplasma Infection (1)
26/35
PCR is superior to traditional culture methods fordetecting M. hominis in genital secretions.
-
8/13/2019 Mycoplasma Infection (1)
27/35
Genitourinary infection Pyelonephritis Pelvic inflammatory disease Chorioamnionitis Postpartum and postabortal feverNongenitourinary infections that have been linked to M. hominis
include: Septicemia
Wound infections Central nervous infections Joint infections Lower respiratory tract infections Endocarditis
-
8/13/2019 Mycoplasma Infection (1)
28/35
Post partum & post abortal fever M. hominis causes approximately 10 percent of all
cases of postpartum and postabortal fever.
There was a fourfold rise in antibody titers in one-halfof all women who had postabortal fever compared to
only 2 of 53 controls who had abortion without fever.
-
8/13/2019 Mycoplasma Infection (1)
29/35
PID M. hominis was isolated from 4 of 50 fluid samples
taken directly from the fallopian tubes of women withsalpingitis.
Significant rises in antibody titers to M. hominis
occurred in 9 of 16 women with salpingitis who hadpositive lower genital tract cultures for M. hominis .
-
8/13/2019 Mycoplasma Infection (1)
30/35
UTI M. hominis can frequently be recovered from the lower
genitourinary tract in men and women.
-
8/13/2019 Mycoplasma Infection (1)
31/35
ChorioamnionitisM. hominis, along with Ureaplasma urealyticum, is
frequently found in the amniotic fluid of women with
i)preterm labor,
ii) preterm premature rupture ofmembranes
iii) spontaneous labor at term
iv) premature rupture of membranes at termv) chorioamnionitis
-
8/13/2019 Mycoplasma Infection (1)
32/35
CNS M. hominis infection has been associated with non-
functioning CNS shunts , brain abscess , subduralempyema, and meningitis.
M. hominis arthritis can occur in women after childbirth,in conjunction with congenital immune defects, such ashypogammaglobulinemia , in association withimmunosuppression (eg, in solid organ transplantpatients) or lymphoma , or following joint replacementsurgery or trauma.
M. hominis arthritis is usually characterized by fever,leukocytosis, and a purulent joint effusion with largenumbers of polymorphonuclear cells but a negative Gramstain.
-
8/13/2019 Mycoplasma Infection (1)
33/35
Wound infections
M. hominis has been associated with infected pelvichematoma , infected cesarean wounds, and sternalwound infections
-
8/13/2019 Mycoplasma Infection (1)
34/35
Treatment Tetracycline is the treatment of choice
-
8/13/2019 Mycoplasma Infection (1)
35/35
Thank you